Clinical trial comparing Lipegfilgrastim to Filgrastim in Pediatric Patients Diagnosed with Ewing Family of Tumors or Rhabdomyosarcoma Receiving Chemotherapy

Update Il y a 4 ans
Reference: EUCTR2015-000087-34

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to assess the efficacy of a single subcutaneous (sc) dose of 100 μg/kg body weight (BW) of lipegfilgrastim per cycle compared to daily 5 μg/kg BW of filgrastim doses in children receiving CTX


Inclusion criteria

  • Neutropenia in pediatric patients diagnosed with Ewing family of Tumors
  • or rhabdomyosarcoma receiving chemotherapy